Wiki-MPM
About
Search
Browse
People
Funding
Updates
Search
AKT2 and APOA1
Data Source:
BioGRID
(two hybrid)
AKT2
APOA1
Description
AKT serine/threonine kinase 2
apolipoprotein A1
Image
GO Annotations
Cellular Component
Nucleus
Nucleoplasm
Early Endosome
Cytosol
Plasma Membrane
Cell Cortex
Ruffle Membrane
Protein-containing Complex
Intracellular Membrane-bounded Organelle
Extracellular Region
Extracellular Space
Nucleus
Early Endosome
Endoplasmic Reticulum Lumen
Cytosol
Plasma Membrane
Cell Surface
Endocytic Vesicle
Cytoplasmic Vesicle
Very-low-density Lipoprotein Particle
Low-density Lipoprotein Particle
Intermediate-density Lipoprotein Particle
High-density Lipoprotein Particle
Discoidal High-density Lipoprotein Particle
Spherical High-density Lipoprotein Particle
Secretory Granule Lumen
Chylomicron
Collagen-containing Extracellular Matrix
Extracellular Exosome
Endocytic Vesicle Lumen
Blood Microparticle
Extracellular Vesicle
Molecular Function
Protein Serine/threonine Kinase Activity
Protein Binding
ATP Binding
Metal Ion Binding
Protein Serine Kinase Activity
Protein Threonine Kinase Activity
Amyloid-beta Binding
Signaling Receptor Binding
Protein Binding
Phospholipid Binding
High-density Lipoprotein Particle Binding
Cholesterol Binding
Enzyme Binding
Heat Shock Protein Binding
Phosphatidylcholine Binding
Apolipoprotein Receptor Binding
Apolipoprotein A-I Receptor Binding
Identical Protein Binding
Chemorepellent Activity
Lipase Inhibitor Activity
Phosphatidylcholine-sterol O-acyltransferase Activator Activity
High-density Lipoprotein Particle Receptor Binding
Cholesterol Transfer Activity
Biological Process
Positive Regulation Of Protein Phosphorylation
Glycogen Biosynthetic Process
Glucose Metabolic Process
Regulation Of Translation
Cellular Protein Modification Process
Signal Transduction
Positive Regulation Of Cell Population Proliferation
Insulin Receptor Signaling Pathway
Carbohydrate Transport
Negative Regulation Of Long-chain Fatty Acid Import Across Plasma Membrane
Positive Regulation Of Glucose Metabolic Process
Positive Regulation Of Mitochondrial Membrane Potential
Peptidyl-serine Phosphorylation
Regulation Of Cell Migration
Positive Regulation Of Cell Migration
Positive Regulation Of Vesicle Fusion
Positive Regulation Of Fatty Acid Beta-oxidation
Peripheral Nervous System Myelin Maintenance
Cellular Response To Insulin Stimulus
Intracellular Signal Transduction
Negative Regulation Of Apoptotic Process
Fat Cell Differentiation
Positive Regulation Of Glycogen Biosynthetic Process
Positive Regulation Of Glucose Import
Mammary Gland Epithelial Cell Differentiation
Intracellular Protein Transmembrane Transport
Regulation Of Cell Cycle Arrest
Cellular Response To High Light Intensity
Protein Localization To Plasma Membrane
Positive Regulation Of Protein Targeting To Membrane
Activation Of GTPase Activity
Retinal Rod Cell Apoptotic Process
Positive Regulation Of Cell Motility
Retinoid Metabolic Process
Regulation Of Protein Phosphorylation
Endothelial Cell Proliferation
Platelet Degranulation
Negative Regulation Of Cytokine Production Involved In Immune Response
Phosphatidylcholine Biosynthetic Process
Cholesterol Biosynthetic Process
Receptor-mediated Endocytosis
Transforming Growth Factor Beta Receptor Signaling Pathway
G Protein-coupled Receptor Signaling Pathway
Integrin-mediated Signaling Pathway
Response To Nutrient
Cholesterol Metabolic Process
Glucocorticoid Metabolic Process
Negative Regulation Of Tumor Necrosis Factor-mediated Signaling Pathway
Positive Regulation Of Cholesterol Esterification
Positive Regulation Of Cholesterol Efflux
Positive Regulation Of Triglyceride Catabolic Process
Negative Regulation Of Very-low-density Lipoprotein Particle Remodeling
Peripheral Nervous System Axon Regeneration
Protein Oxidation
Peptidyl-methionine Modification
Regulation Of Lipid Metabolic Process
Lipid Storage
Regulation Of Intestinal Cholesterol Absorption
Cholesterol Transport
Adrenal Gland Development
Animal Organ Regeneration
Regulation Of Cdc42 Protein Signal Transduction
Negative Regulation Of Interleukin-1 Beta Production
Cholesterol Efflux
Phospholipid Efflux
Negative Regulation Of Heterotypic Cell-cell Adhesion
Chylomicron Remodeling
Very-low-density Lipoprotein Particle Remodeling
High-density Lipoprotein Particle Remodeling
Chylomicron Assembly
High-density Lipoprotein Particle Assembly
High-density Lipoprotein Particle Clearance
Positive Regulation Of Rho Protein Signal Transduction
Lipoprotein Metabolic Process
Lipoprotein Biosynthetic Process
Response To Drug
Cholesterol Homeostasis
Blood Vessel Endothelial Cell Migration
Response To Estrogen
Post-translational Protein Modification
Reverse Cholesterol Transport
Cellular Protein Metabolic Process
Positive Regulation Of Fatty Acid Biosynthetic Process
Phosphatidylcholine Metabolic Process
Positive Regulation Of Lipid Biosynthetic Process
Negative Regulation Of Inflammatory Response
Positive Regulation Of Phagocytosis
Protein Stabilization
Negative Chemotaxis
Positive Regulation Of Lipoprotein Lipase Activity
Vitamin Transport
Positive Regulation Of Hydrolase Activity
Positive Regulation Of Stress Fiber Assembly
Transmembrane Transport
Phospholipid Homeostasis
Negative Regulation Of Lipase Activity
Negative Regulation Of Cell Adhesion Molecule Production
Negative Regulation Of Response To Cytokine Stimulus
Triglyceride Homeostasis
ERK1 And ERK2 Cascade
Cholesterol Import
Intermembrane Lipid Transfer
Positive Regulation Of Substrate Adhesion-dependent Cell Spreading
Positive Regulation Of Phospholipid Efflux
Pathways
Activation of BAD and translocation to mitochondria
PIP3 activates AKT signaling
PIP3 activates AKT signaling
Downregulation of ERBB2:ERBB3 signaling
Translocation of SLC2A4 (GLUT4) to the plasma membrane
Activation of AKT2
PDE3B signalling
Inhibition of TSC complex formation by PKB
AKT phosphorylates targets in the cytosol
AKT phosphorylates targets in the cytosol
AKT phosphorylates targets in the nucleus
Negative regulation of the PI3K/AKT network
AKT-mediated inactivation of FOXO1A
Deactivation of the beta-catenin transactivating complex
CD28 dependent PI3K/Akt signaling
CTLA4 inhibitory signaling
G beta:gamma signalling through PI3Kgamma
VEGFR2 mediated vascular permeability
TP53 Regulates Metabolic Genes
Constitutive Signaling by AKT1 E17K in Cancer
Regulation of TP53 Degradation
Regulation of TP53 Activity through Acetylation
Regulation of TP53 Activity through Association with Co-factors
Cyclin E associated events during G1/S transition
Cyclin A:Cdk2-associated events at S phase entry
RAB GEFs exchange GTP for GDP on RABs
RUNX2 regulates genes involved in cell migration
Regulation of PTEN stability and activity
FLT3 Signaling
Regulation of localization of FOXO transcription factors
Estrogen-dependent nuclear events downstream of ESR-membrane signaling
Platelet degranulation
ABC transporters in lipid homeostasis
PPARA activates gene expression
Scavenging of heme from plasma
Scavenging by Class B Receptors
Scavenging by Class B Receptors
Scavenging by Class A Receptors
Scavenging by Class A Receptors
Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)
Defective ABCA1 causes TGD
Post-translational protein phosphorylation
Chylomicron assembly
HDL assembly
Chylomicron remodeling
HDL clearance
HDL remodeling
Retinoid metabolism and transport
Retinoid metabolism and transport
Amyloid fiber formation
Drugs
N-[(1S)-2-amino-1-phenylethyl]-5-(1H-pyrrolo[2,3-b]pyridin-4-yl)thiophene-2-carboxamide
4-(4-CHLOROPHENYL)-4-[4-(1H-PYRAZOL-4-YL)PHENYL]PIPERIDINE
ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CHLOROBENZYLOXY)ETHYLAMINO)ETHYL)AMIDE
(2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}PROPAN-2-AMINE
Zinc
Copper
Zinc acetate
Zinc chloride
Zinc sulfate, unspecified form
Diseases
Familial partial lipodystrophy (FPL), including the following four diseases: Kobberling-type lipodystrophy (FPLD1); Dunnigan-type lipodystrophy (FPLD2); Dunnigan-like lipodystrophy (FPLD3); AKT2 associated lipodystrophy
Ovarian cancer
Hypoalphalipoproteinemia
Familial amyloidosis
GWAS
Birth weight (
31043758
)
Cerebrospinal fluid t-tau:AB1-42 ratio (
26252872
)
Cerebrospinal T-tau levels (
26252872
)
Diastolic blood pressure (
28739976
)
Lean body mass (
28552196
)
Lymphocyte counts (
32888494
)
Monocyte count (
32888494
)
Allergic rhinitis (
30013184
)
Apolipoprotein A1 levels (
32203549
)
Blood protein levels (
29875488
)
Body mass index (
31978080
)
Cholesterol, total (
24097068
19060911
20686565
)
Coronary artery disease (
24262325
)
Coronary artery disease (myocardial infarction, percutaneous transluminal coronary angioplasty, coronary artery bypass grafting, angina or chromic ischemic heart disease) (
28714975
)
Coronary heart disease (
21378990
)
Delirium (
29631748
)
Diastolic blood pressure (
27841878
)
Fasting triglyceride levels (
32603185
)
HDL cholesterol (
24097068
20864672
19060906
20686565
26582766
)
HDL cholesterol levels (
28334899
)
Hearing function (
25060954
)
Hematological and biochemical traits (
20139978
)
Hypertriglyceridemia (
27599772
23505323
)
Infantile hypertrophic pyloric stenosis (
23989729
)
LDL cholesterol (
24097068
18179892
20864672
19060911
20686565
)
LDL cholesterol levels (
28334899
)
Lipid metabolism phenotypes (
22286219
)
Lipid traits (
24386095
)
Metabolite levels (
22916037
)
Postprandial triglyceride levels (
32603185
)
Serum metabolite levels (
31636271
)
Serum metabolite levels (CMS) (
31636271
)
Systolic blood pressure (
27841878
)
Total cholesterol levels (
28334899
)
Total triglycerides levels (
26690388
)
Triglyceride levels (
28334899
26763881
28371326
28548082
)
Triglycerides (
24097068
19074352
21909109
18193043
18193044
18193046
20864672
19060906
19060911
20139978
20686565
26582766
)
Very low density lipoprotein cholesterol levels (
28548082
)
Interacting Genes
44 interacting genes:
ABCG8
AKT1
AKT1S1
APOA1
APOB
APP
APPL1
BLVRA
CCL14
CDKN1A
CHUK
CLIP3
ESR1
FOXO4
FSHR
GSK3B
H3C1
HSP90AA1
MEOX2
MTCP1
NAMPT
PDPK1
PICK1
PIP5K1C
PLEKHO1
PNPLA3
POFUT1
POLR1B
PRKDC
RAB3D
REL
SH3RF1
SLC2A4
SNX27
SORBS2
SORBS3
SPRR2A
STEAP4
TCL1A
TCL1B
TMED2
TRIB3
TSC2
XIAP
38 interacting genes:
ABCA1
ABCA13
AKT2
APOA2
APOB
APOC1
APOF
APOL1
APP
ATP5F1B
BRAP
CETP
CFHR1
CLEC4G
CMTM5
FBLN1
GPLD1
HP
HPR
JAK3
LBP
LCAT
MAP7D1
NAXE
NDRG1
PCMT1
PDE1A
PLTP
POLR1H
PON1
SAA2
SCARB1
SPP1
TNFRSF10C
TOMM20
TREM2
TTR
VKORC1
Entrez ID
208
335
HPRD ID
01262
02517
Ensembl ID
ENSG00000105221
ENSG00000118137
Uniprot IDs
B4DG79
P31751
A0A024R3E3
P02647
PDB IDs
1GZK
1GZN
1GZO
1MRV
1MRY
1O6K
1O6L
1P6S
2JDO
2JDR
2UW9
2X39
2XH5
3D0E
3E87
3E88
3E8D
1AV1
1GW3
1GW4
1ODP
1ODQ
1ODR
2MSC
2MSD
2MSE
2N5E
3K2S
3R2P
4V6M
6CC9
6CCH
6CCX
6CLZ
6CM1
6PTS
6PTW
6W4E
6W4F
Enriched GO Terms of Interacting Partners
?
Tagcloud
?
Tagcloud (Difference)
?
Tagcloud (Intersection)
?